Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
From 23. Aug. 1995 to 06. Sep. 1995
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1995
Report date:
1995

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Version / remarks:
1987
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.3 (Acute Toxicity (Dermal))
Version / remarks:
1992
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Reference substance name:
-
EC Number:
424-510-1
EC Name:
-
Cas Number:
220150-59-4
Molecular formula:
not applicable for UVCB substance
IUPAC Name:
Reaction products of Phenol, 2,4-dinitro-, sulfurized, leuco derivatives and (3-chloro-2-hydroxypropyl)trimethylammonium chloride

Test animals

Species:
rat
Strain:
Wistar
Remarks:
Hanlbm: WIST (SPF)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: BRL, Biological Research Laboratories Ltd., Wolferstrasse 4, 4414 Füllinsdorf, CH
- Females nulliparous and non-pregnant: not specified
- Age at study initiation: males: 8 weeks; females: 11 weeks
- Weight at study initiation: males: 220 to 239 g; females: 187 to 213 g
- Fasting period before study: not specified
- Housing: acclimatisation: in groups of five in Makrolon type-4 cages; during treatment and observation: individually in Makrolon type-3 cages. Autoclaved standard softwood bedding ("Lignocel", Schill AG, 4132 Muttenz, CH).
- Diet: ad libitum; pelleted standard Kliba 343, batch nos. 86/95 and 65/95 rat maintenance diet ("Kliba", Klingentalmühle AG, 4303 Kaiseraugst, CH). Results of analyses for contaminants included in report.
- Water: ad libitum; community tap water from Füllinsdorf. Bacteriological, chemical and contaminant analyses included.
- Acclimation period: one week under laboratory conditions, after health examination. Only animals without any visible signs of illness were used for the study.
- Identification: by unique cage number and corresponding colour-coded spots on the tail
- Randomisation: randomly selected at the time of delivery into groups of five

ENVIRONMENTAL CONDITIONS
- Temperature: 21.5 to 23 °C
- Humidity: 54 to 76 %
- Air changes: 10 to 15 per hour
- Photoperiod (hrs dark / hrs light): 12 / 12

Administration / exposure

Type of coverage:
semiocclusive
Vehicle:
water
Remarks:
bi-distilled water
Details on dermal exposure:
TEST SITE
- Area of exposure: dorsal area, clipped one day before test item application
- Coverage: 10 % of body surface area
- Type of wrap if used: semi-occlusive

REMOVAL OF TEST SUBSTANCE
- Washing: washed with lukewarm tap water and dried with disposable paper towels
- Time after start of exposure: 24 hours

TEST MATERIAL
- Amount applied: 4 mL/kg bw
- Concentration: 2000 mg/kg bw
- Constant volume used: no
- Constant concentration used: yes
- For solids, paste formed: yes

Duration of exposure:
24 hours
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
Males (2000 mg/kg bw): 5
Females (2000 mg/kg bw): 5
Total: 10
Control animals:
no
Details on study design:
- Observations: clinical signs, body weight, mortality, pathological change
- Duration of observation period following administration: 14 days
- Frequency of observations: four times during test day 1 then daily during days 2 to 15
- Frequency of weighing: on test days 1 (pre-administration), 8 and 15
- Necropsy of survivors performed: yes. Necropsies were performed by experienced prosectors. At the end of the observation period all animals were anaesthetised by intraperitoneal injection of NARCOREN (Rhone Merieux GmbH, 88471 Laupheim, Germany) at a dose of at least 2.0 ml/kg bw (equivalent to at least 320 mg/kg sodium pentobarbitone /kg bw) and sacrificed by exsanguination. The animals were examined macroscopically.

CLINICAL SIGNS:
General behaviour: aggressiveness, vocalisation, restlessness / excitation, nervousness, fear, sedation, somnolence, sleep, coma
Respiration: apnoea, dyspnea, rales
Eye: chromodacryorrhoea, exophthalmos, miosis, mydriasis, whitish discharge, lid adhesion, lacrimation, negative corneal reflex
Nose: rhinorrhoea, epistaxis
Motility: akinesia, ataxia, dropped head, hyperkinesia, hypokinesia, paralysis (flaccid), paralysis (spastic), paddling movements, stiff gait, rolling movements
Body posture: ventral body position, latero-abdominal position, hunched posture
Motor susceptibility: spasms, tonic muscle spasms, clonic muscle spasms, opisthotonus, saltatory spasms, trismus, tremor, muscle-twitching, muscle-twitching (generalised)
Skin: erythema, oedema, necrosis
Various: loss of weight, emaciation, diarrhoea, ruffled fur, salivation, pallor, cyanosis
Statistics:
The LOGIT-Model could not be used as no deaths occurred.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No deaths occurred during the study period.
Clinical signs:
other: There were no clinical signs of systemic toxiclty. The skin was discoloured with blue at the application site in all animals. The staining persisted on test days 2 to 15. In one male animal the blue discoloured skin was observed until test day 8.
Gross pathology:
No macroscopic findings were noted.

Applicant's summary and conclusion

Interpretation of results:
other: not classified according to the CLP criteria (EC 1272/2008)
Conclusions:
The LD50 (dermal, rat) of test item was found to be greater than 2000 mg/kg bw.
Executive summary:

Acute dermal toxicity of the test item was evaluated in an experimental study that was performed according to the OECD Guideline 402 (1987) and EU method B.3 (1992). 2000 mg/kg bw of the test item was applied dorsally to 10 rats of both sexes for a duration of 24 hours.

A death rate of 0 % at 2000 mg/kg bw was observed. Local discolouration was observed between 24 hours and end of observation period. The LOGIT-Model could not be applied to these data. The acute dermal toxicity of the test item in rats of both sexes observed over a period of 15 days was estimated to be greater than 2000 mg/kg bw. Therefore, it can be extrapolated that the LD50 (dermal, rat) is greater than 2000 mg/kg bw.